Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02823431 · ClinicalTrials.gov registry record · NA
Effect of Urethral Analgesia on Voiding
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02823431: Completed NA study, sponsored by Duke University.
NCT02823431 is a NA study that has completed, run by Duke University. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02823431, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how urethral analgesia impacts voiding efficiency in healthy women. The investigator hypothesizes that anesthetizing the urethral with lidocaine gel will decrease voiding efficiency as measured by standard bladder testing (urodynamic testing).
Primary Outcome
voided volume/{voided volume + residual volume} during micturition study during urodynamic studies
Interventions
- DRUG lidocaine gel
- OTHER Plain aqueous gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-07 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT02823431 record still lists
NCT02823431 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which lidocaine gel is the first listed.
NCT02823431 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02823431 about?
NCT02823431 is a clinical study titled "Effect of Urethral Analgesia on Voiding". The purpose of this study is to evaluate how urethral analgesia impacts voiding efficiency in healthy women. The investigator hypothesizes that anesthetizing the urethral with lidocaine gel will decrease voiding efficiency as measured by standard bladder testing (urodynamic testing).
What is the current status of trial NCT02823431?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-07. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02823431?
The interventions under investigation include: lidocaine gel (DRUG), Plain aqueous gel (OTHER).
Who is sponsoring clinical trial NCT02823431?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02823431's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia